Patients with metastatic carcinoid tumours often undergo surgical procedure
s to reduce the tumour burden and associated debilitating symptoms. These p
rocedures and anaesthesia can precipitate a life-threatening carcinoid cris
is. To assess perioperative outcomes, we studied retrospectively the medica
l records of adult patients from 1983 to 1996 who underwent abdominal surge
ry for metastatic carcinoid tumours. Preoperative risk factors, intraoperat
ive complications and complications occurring in the 30 days after surgery
were recorded. Perioperative complications or death occurred in 15 of 119 p
atients (12.6%, exact confidence interval 7.2-19.9). None of the 45 patient
s who received octreotide intraoperatively experienced intraoperative compl
ications compared with eight of the 73 patients (11.0%) who did not receive
octreotide (P=0.023). The presence of carcinoid heart disease and high uri
nary output of 5-hydroxyindoleacetic acid preoperatively were statistically
significant risk factors for perioperative complications.